Advertisement

Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis

Published:December 28, 2018DOI:https://doi.org/10.1016/j.gie.2018.12.018

      Background and Aims

      Gastric cancer (GC) is a newly described cancer risk in Western patients with familial adenomatous polyposis (FAP). Little is known about clinical, endoscopic, and pathologic features associated with FAP-related GC. We compared these features in FAP patients with and without GC.

      Methods

      FAP patients were identified through the David G. Jagelman Inherited Colorectal Cancer Registries Cologene database. FAP patients with GC and randomly selected FAP patients without GC who had undergone at least 2 EGDs were analyzed. Demographic, clinical, endoscopic, and pathologic features were compared.

      Results

      Ten FAP patients with GC were identified, and 40 age-matched FAP control subjects were selected. No demographic differences were noted between patients and control subjects. All GC cases arose in the proximal stomach among gastric polyposis, with only 2 endoscopically visible. The prevalence of gastric polyposis was similar (100% vs 93%). Endoscopic features associated with GC included a carpeting of gastric polyps (100% vs 22.5%), solitary polyps >20 mm (100% vs 0%), and a polypoid mound of polyps (80% vs 0%; all P < .001). GC patients had a higher prevalence of gastric adenomas (30% vs 5%, P = .048) and polyps with high-grade dysplasia, including fundic gland polyps (50% vs 10%, P = .01) and pyloric gland adenomas (20% vs 0%, P = .037).

      Conclusions

      We identified endoscopic features and advanced pathology present in the stomachs of Western patients with FAP who developed GC. Upper GI surveillance in FAP should include the stomach and awareness of features associated with GC. Optimal approaches to treatment of gastric polyposis and methods of identification of early GC precursors in FAP are needed.

      Abbreviations:

      APC (adenomatous polyposis coli), FAP (familial adenomatous polyposis), GC (gastric cancer), PPI (proton pump inhibitor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ghorbanoghil Z.
        • Bastiaansen B.A.
        • Langers A.M.
        • et al.
        Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis.
        J Med Genet. 2018; 55: 11-14
        • National Comprehensive Cancer Network
        Colorectal cancer screening: genetic familial high risk assessment.
        (Available at:) (Accessed January 11, 2018)
        • Syngal S.
        • Brand R.
        • Church J.
        • et al.
        ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes.
        Am J Gastroenterol. 2015; 110: 223-262
        • Park J.G.
        • Ahn K.J.
        • Song Y.O.
        • et al.
        Risk of gastric cancer among Korean familial adenomatous polyposis patients: report of 3 cases.
        Dis Colon Rectum. 1992; 35: 996-998
        • Shibata C.
        • Ogawa H.
        • Miura J.
        • et al.
        Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis.
        Tohoku J Exp Med. 2013; 229: 143-146
        • Mankaney G.
        • Leone P.
        • Cruise M.
        • et al.
        Gastric cancer in FAP: a concerning rise in incidence.
        Fam Cancer. 2017; 16: 371-376
        • Walton S.J.
        • Frayling I.M.
        • Clark S.K.
        • et al.
        Gastric tumours in FAP.
        Fam Cancer. 2017; 16: 363-369
        • Bianchi L.K.
        • Burke C.A.
        • Bennett A.
        • et al.
        Fundic gland polyp dysplasia is common in familial adenomatous polyposis.
        Clin Gastroenterol Hepatol. 2008; 6: 180-185
        • Burt R.
        Gastric fundic gland polyps.
        Gastroenterology. 2003; 125: 1462-1469
        • Abraham S.C.
        • Nobukawa B.
        • Giardiello F.M.
        • et al.
        Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations.
        Am J Pathol. 2000; 157: 747-754
        • Lida M.
        • Yao T.
        • Itoh H.
        • et al.
        Natural history of fundic gland polyps in patients with familial adenomatosis coli/Gardner’s syndrome.
        Gastroenterology. 1985; 89: 1021-1025
        • Odze R.
        Gastric fundic gland polyps: are they preneoplastic lesions?.
        Gastroenterology. 1998; 114: 422-423
        • Hofgartner W.T.
        • Thorp M.
        • Ramus M.W.
        • et al.
        Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis.
        Am J Gastroenterol. 1999; 94: 2275-2281
        • Zwick A.
        • Munir M.
        • Ryan C.K.
        • et al.
        Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli.
        Gastroenterology. 1997; 113: 659-663
        • Wood L.D.
        • Salaria S.N.
        • Cruise M.W.
        • et al.
        Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms.
        Am J Surg Pathol. 2014; 38: 389-393
        • Kherad Pezhouh M.
        • Park J.Y.
        Gastric pyloric gland adenoma.
        Arch Path Lab Med. 2015; 139: 823-826
        • Iwama T.
        • Mishima Y.
        • Utsunomiya J.
        The impact of familial adenomatous polyposis on tumorigenesis and mortality at the several organs. Its rational treatment.
        Ann Surg. 1993; 217: 101-108
        • Mankaney G.
        • Burke C.A.
        • Cruise M.
        • et al.
        Endoscopic ultrasound imaging detection of gastric cancer in familial adenomatous polyposis.
        Gastroenterology. 2017; 153: 353-354
        • Calvas L.
        • Rivory J.
        • Hervieu V.
        • et al.
        Macroscopically visible flat dysplasia in the fundus of 3 patients with familial adenomatous polyposis.
        Gastrointest Endosc. 2017; 86: 679-680
        • Das Kunnathu N.
        • Mankaney G.
        • Leone P.
        • et al.
        Worrisome endoscopic feature in the stomach of patients with familial adenomatous polyposis: the proximal white mucosal patch.
        Gastrointest Endosc. 2018; 88: 569-570
        • Togo K.
        • Ueo T.
        • Yonemasu H.
        • et al.
        Two cases of adenocarcinoma in sporadic fundic gland polyps observed by magnifying endoscopy with narrow band imaging.
        World J Gastroenterol. 2006; 22: 9028-9034
        • Lopez-Ceron M.
        • Van de Broek F.J.
        • Mathus-Vilegen E.M.
        • et al.
        The role of high-resolution endoscopy and narrow band imaging in the evaluation of upper GI neoplasia in familial adenomatous polyposis.
        Gastrointest Endosc. 2013; 77: 542-550